The functioning of IFN-γ is mediated through its receptors, IFNGR1 and IFNGR2, and when the signaling pathways are dysregulated, it can significantly contribute to the pathogenesis of autoimmune diseases such as SLE and RA [18]. This evidence concerns the gene IFNGR1 and systemic lupus erythematosus.